Oppenheimer Asset Management Inc. Horizon Therapeutics Public LTD CO Transaction History

Oppenheimer Asset Management Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$62.39 - $113.8 $43,673 - $79,660	-700 Reduced 1.8%	38,191 $4.35 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $63,869 - $91,782	-1,084 Reduced 2.71%	38,891 $2.41 Million
Q2 2022 Aug 08, 2022	SELL	$79.4 - $116.36 $141,729 - $207,702	-1,785 Reduced 4.27%	39,975 $3.19 Million
Q1 2022 May 12, 2022	SELL	$86.42 - $109.81 $113,037 - $143,631	-1,308 Reduced 3.04%	41,760 $4.39 Million
Q4 2021 Feb 02, 2022	SELL	$98.56 - $119.91 $66,626 - $81,059	-676 Reduced 1.55%	43,068 $4.64 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $52,664 - $63,242	-573 Reduced 1.29%	43,744 $4.79 Million
Q2 2021 Aug 03, 2021	SELL	$86.24 - $95.92 $100,038 - $111,267	-1,160 Reduced 2.55%	44,317 $4.15 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $590,801 - $785,323	8,225 Added 22.08%	45,477 $4.19 Million
Q4 2020 Feb 11, 2021	BUY	$67.0 - $84.39 $549,199 - $691,744	8,197 Added 28.21%	37,252 $2.73 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $28,056 - $40,604	-508 Reduced 1.72%	29,055 $2.26 Million
Q2 2020 Aug 11, 2020	BUY	$30.2 - $56.98 $892,802 - $1.68 Million	29,563 New	29,563 $1.64 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.